Back to results
US 2023/0398206 A1Published application
Method and kit for detection of cell mediated immune response
AssigneeBioVaxys Inc.
InventorsDavid Berd, James Passin
Life of this patent
Estimating the term…
Abstract
The invention relates to a method of eliciting an immune response in a human subject showing no signs or symptoms of an active SARS-CoV-2 infection comprising administering intra-dermally to the human subject an immunogenic composition comprising the Spike protein (S protein) of SARS-CoV-2 or a fragment thereof.
Claims21
A method of eliciting an immune response in a human subject showing no signs or symptoms of an active SARS-CoV-2 infection comprising administering intra-dermally to the human subject an immunogenic composition comprising the Spike protein (S protein) of SARS-CoV-2 or a fragment thereof.
21-25. (canceled)
Dependencies are inferred from the claim text.